Pharmacist's Letter Canada | Convenient Monthly Updates + CE

September 2026 Issue

Know What's New With Flu Vaccines for 2026-2027

Patients will look to you for guidance on 2026-2027 flu vaccines…

Resources

Chart: Comparison of Pneumococcal Vaccines
Chart: RSV Vaccines
FAQ: Shingles Vaccine (Shingrix) FAQs
FAQ: Tetanus Prevention and Vaccination
Chart: Flu Vaccines for 2026-27 (Canada)
FAQ: Communicating About Flu Vaccination

Watch for Tirzepatide for Sleep Apnea

Tirzepatide (Zepbound) will be the first med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity…

When Kids Have Type 2 Diabetes: A Treatment Guide

You’ll have more opportunities to help manage type 2 diabetes in children and teens...

Answer Common Questions About COVID-19 Vaccines

Questions will come up about 2026-2027 COVID-19 vaccines…

GO TO FULL ISSUE

CE & Training

Healthcare image with scattered pills on blue surface representing wellness and lifestyle.

INTERACTIVE SELF-STUDY CE: Comprehensive Diabetes Care: Navigating Complications and Acute Scenarios

CE-IN-THE-LETTER: Pharmacist's Letter Canada September 2026

LIVE CE: Pharmacy Essential Updates September 2026

PODCAST CE: Medication Talk - Estimating Kidney Function in Chronic Kidney Disease

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Inhalation Medications for Asthma (Canada)

Stepwise Treatment of Asthma j12 Years and Older

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information